LONDON (AP) – Two Americans and a British scientist won the 2019 Nobel Prize for Physiology or Medicine for discovering how the body’s cells sense and react to oxygen levels, work that has paved the way for new strategies to fight anemia, cancer and other diseases, the Nobel Committee said.
Drs. William G. Kaelin Jr. of Harvard University, Gregg L. Semenza of Johns Hopkins University and Peter J. Ratcliffe at the Francis Crick Institute in Britain and Oxford University will share equally the 9 million kronor ($918,000) cash award, the Karolinska Institute said.
It is the 110th prize in the category that has been awarded since 1901.
Their work has “greatly expanded our knowledge of how physiological response makes life possible,” the committee said, explaining that the scientists identified the biological machinery that regulates how genes respond to varying levels of oxygen.
That response is key to things like producing red blood cells, generating new blood vessels and fine-tuning the immune system.
The Nobel Committee said scientists are focused on developing drugs that can treat diseases by either activating or blocking the body’s oxygen-sensing machinery.
The oxygen response is hijacked by cancer cells, for example, which stimulate formation of blood vessels to help themselves grow. And people with kidney failure often get hormonal treatments for anemia, but the work of the new laureates points the way toward new treatments, Nils-Goran Larsson of the Nobel committee told The Associated Press.
Reached at his home, Kaelin said he was half-asleep Monday morning when the phone rang. It was Stockholm.
“I was aware as a scientist that if you get a phone call at 5 a.m. with too many digits, it’s sometimes very good news, and my heart started racing. It was all a bit surreal,” he said.
Kaelin said he isn’t sure yet how he’ll spend the prize money but “obviously I’ll try to put it to some good cause.” Kaelin is paid by the Howard Hughes Medical Institute, which also supports AP’s Health and Science Department with some grants.
Ratcliffe told Sweden’s news agency TT that “when I started my research, I also had no idea that it would result in this.”
He added the impact of oxygen on cells “has not always been a trendy area to research, and some people have doubted them during the journey.”
In Baltimore, Semenza said it was when he and colleagues were studying a gene in a rare cell type in the kidney and they did an experiment that showed the factor they discovered – which was linked to oxygen – that suggested it had widespread physiological importance. They were studying erythropoietin, or EPO, which controls red blood cell production. The body turns on EPO when cells in the kidney don’t get enough oxygen.
“We found it very interesting that the body can respond to oxygen,” he told the AP. That discovery has led to treatments for people with chronic kidney disease who become anemic when their kidneys stop making EPO. “Now, drugs can turn on EPO production by increasing these factors.”
Semenza said it was likely one or more of these drugs will be approved for production in the next few years and that one has already been green-lighted in China.
Semenza has gone on to author more than 400 research articles and book chapters.
Andrew Murray of the University of Cambridge said the three laureates’ discovery was fundamental to understanding how to combat diseases of the heart and lungs as well as numerous cancers.
“Low oxygen levels are a feature of some of the most life-threatening diseases,” he said. “When cells are short of oxygen, as is the case with heart failure and lung disease, the tissues need to respond to that in order to maintain energy levels.”
Murray said the case of cancer was slightly different. Some cancer tumors thrive under low oxygen conditions, so Murray said scientists are trying to develop drugs to manipulate oxygen levels under these circumstances.
“The work they have done is already leading the way to drugs that manipulate oxygen sensing pathways,” he said.
He added the discovery pointed to an even more basic principle of human evolution. Murray said that particular traits have been noted in people who live at high altitude, like those on the Tibetan plateau, whose bodies have adapted to low oxygen.
Last year, James Allison of the United States and Tasuku Honjo of Japan won the 2018 Nobel Prize for Medicine for their work in immunotherapy, activating the body’s natural defense system to fight tumors.
Monday’s announcement kicked off this year’s Nobel Prizes. The Nobel Physics prize is handed out Tuesday, followed by the chemistry prize on Wednesday. This year’s double-header Literature Prizes – one each for 2018 and 2019 – will be awarded Thursday and the Peace Prize will be announced on Friday.
The economics prize will be awarded on Oct. 14.
The 2018 Nobel Literature prize was suspended after a sex abuse scandal rocked the Swedish Academy, the body that awards the literature prizes, so they are awarding two prizes this year.
The economics prize – officially known as the Bank of Sweden Prize in Economic Sciences in Memory of Alfred Nobel – wasn’t created by Nobel, but by Riksbanken, Sweden’s central bank, in 1968. The Royal Swedish Academy of Sciences selects that winner.
The laureates will receive their awards at elegant ceremonies in Stockholm and Oslo on Dec. 10 – the anniversary of Nobel’s death in 1896.
Read more stories on the 2019 Nobel Prizes by The Associated Press at https://www.apnews.com/NobelPrizes
Chester reported from New York and Warren reported from Atlanta. Jan M. Olsen in Copenhagen, Denmark, David Keyton in Stockholm and Malcolm Ritter in New York contributed.